Your email has been successfully added to our mailing list.

×
0.00826446280991736 0.00826446280991736 -0.00826446280991736 0 0.00826446280991736 0.0247933884297521 0.0330578512396695 0.0206611570247935
Stock impact report

Arena Pharmaceuticals prices equity offering; shares slip 19% premarket [Seeking Alpha]

Arena Pharmaceuticals, Inc. (ARNA) 
Last arena pharmaceuticals, inc. earnings: 2/26 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: invest.arenapharm.com/investor-relations
Company Research Source: Seeking Alpha
Arena Pharmaceuticals ( ARNA ) slumps   in response to the pricing of its public offering of 60M shares of common stock at $1.15 per share. Underwriters over-allotment is an additional 9M shares. Gross proceeds are $69M. Net proceeds will be used for clinical and preclinical development of drug candidates, for general corporate purposes, including working capital. Closing date is  April 21. Now read: Progenics Pharmaceuticals: Is It Time To Buy? » Show less Read more
Impact Snapshot
Event Time:
ARNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for ARNA alerts
Opt-in for
ARNA alerts

from News Quantified
Opt-in for
ARNA alerts

from News Quantified